Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery

NCT07099859 is registered in ClinicalTrials.gov with Vitor Emer Egypto Rosa as lead sponsor.

NCT NCT07099859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery
Lead sponsor
Vitor Emer Egypto Rosa
Phase
Phase 4
Overall status
Recruiting
Start date
July 1, 2025
Completion date
July 1, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation disease, heart failure congestive, heart valve diseases, left ventricle remodeling, natriuretic peptide, brain